Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Vannata

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Leukemia Research|February 10, 2009
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphomaStefan Hohaus, Manuela Giachelia, Giuseppina Massini, et al.
American Journal of Hematology|April 11, 2012
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantationBarbara Vannata, Luca Laurenti, Patrizia Chiusolo, et al.
Hematological Oncology|October 26, 2020
A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B-cell lymphomasBarbara Vannata, Anna Vanazzi, Mara Negri, et al.
Leukemia & Lymphoma|November 4, 2009
Intravascular large B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negativeValentina Bozzoli, Maria Chiara Tisi, Francesco D'Alò, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 14, 2013
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre ExperienceLuca Laurenti, Barbara Vannata, Idanna Innocenti, et al.
Annals of Hematology|December 6, 2013
Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcomeLaura De Padua, Luca Laurenti, Paolo Falcucci, et al.
British Journal of Haematology|August 7, 2019
Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcomeBarbara Vannata, Annarita Conconi, Jonas Winkler, et al.
Mediterranean Journal of Hematology and Infectious Diseases|September 14, 2012
Regulatory T-cells in chronic lymphocytic leukemia and autoimmune diseasesGiovanni D'Arena, Giovanni Rossi, Barbara Vannata, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidinStefan Hohaus, Giuseppina Massini, Manuela Giachelia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2011
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphomaStefan Hohaus, Rosaria Santangelo, Manuela Giachelia, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Leukemia Research|February 10, 2009
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphomaStefan Hohaus, Manuela Giachelia, Giuseppina Massini, et al.
American Journal of Hematology|April 11, 2012
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantationBarbara Vannata, Luca Laurenti, Patrizia Chiusolo, et al.
Hematological Oncology|October 26, 2020
A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B-cell lymphomasBarbara Vannata, Anna Vanazzi, Mara Negri, et al.
Leukemia & Lymphoma|November 4, 2009
Intravascular large B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negativeValentina Bozzoli, Maria Chiara Tisi, Francesco D'Alò, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 14, 2013
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre ExperienceLuca Laurenti, Barbara Vannata, Idanna Innocenti, et al.
Annals of Hematology|December 6, 2013
Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcomeLaura De Padua, Luca Laurenti, Paolo Falcucci, et al.
British Journal of Haematology|August 7, 2019
Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcomeBarbara Vannata, Annarita Conconi, Jonas Winkler, et al.
Mediterranean Journal of Hematology and Infectious Diseases|September 14, 2012
Regulatory T-cells in chronic lymphocytic leukemia and autoimmune diseasesGiovanni D'Arena, Giovanni Rossi, Barbara Vannata, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidinStefan Hohaus, Giuseppina Massini, Manuela Giachelia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2011
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphomaStefan Hohaus, Rosaria Santangelo, Manuela Giachelia, et al.
Pageof 3